ELAB
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- PMGC Holdings terminated its previously announced acquisition LOI following due diligence and reaffirmed its disciplined M&A strategy while expanding investments in aerospace and defense manufacturingAug 26, 2026
- NorthStrive Biosciences reported positive Phase III results from its AI-driven drug discovery program with Yuva BiosciencesJul 1, 2026
- NorthStrive Biosciences filed two new U.S. patent applications targeting muscle preservation in GLP-1 and next-generation obesity treatmentsJun 18, 2026
- NorthStrive Biosciences filed a new U.S. patent application for EL-22 targeting muscle preservation in humansApr 28, 2026
- NorthStrive Biosciences launched a preclinical study of EL-32 evaluating muscle preservation during GLP-1 weight loss therapyMar 10, 2026